ACM
ROIV icon

Aster Capital Management’s Roivant Sciences ROIV Stock Holding History

Aster Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
5,868
+5,656
+2,668% +$167K 0.04% 408
2026
Q1 		$2.14K Sell
212
-1,776
-89% -$45.6K ﹤0.01% 755
2025
Q4 		$43.1K Sell
1,988
-2,417
-55% -$47.7K 0.02% 493
2025
Q3 		$66.6K Buy
4,405
+1,900
+76% +$23.5K 0.03% 446
2025
Q2 		$28.2K Buy
+2,505
New +$27.2K 0.01% 670
2025
Q1 		– Sell
-3,261
Closed -$38.6K – 1612
2024
Q4 		$38.6K Buy
+3,261
New +$38.6K 0.01% 534

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Aster Capital Management's ROIV Position: Q2 2026 in Review

Aster Capital Management increased its Roivant Sciences (ROIV) stake by 2,668% in Q2 2026, buying an estimated $167K and bringing the position to 5,868 shares worth $208K. The position accounts for 0.04% of the portfolio, ranked #408.

Aster Capital Management first reported a position in ROIV in Q4 2024 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Aster Capital Management held 5,868 shares of Roivant Sciences worth $208K as of Q2 2026.
  • Aster Capital Management bought 5,656 Roivant Sciences shares in Q2 2026, an estimated $167K.
  • Roivant Sciences made up 0.04% of Aster Capital Management's portfolio in Q2 2026, its #408 holding.
  • Aster Capital Management first reported a position in Roivant Sciences in Q4 2024 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.